
Michael A. Matey
Examiner (ID: 10696, Phone: (571)270-5648 , Office: P/2835 )
| Most Active Art Unit | 2835 |
| Art Unit(s) | 2841, 2835 |
| Total Applications | 842 |
| Issued Applications | 659 |
| Pending Applications | 76 |
| Abandoned Applications | 122 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17290944
[patent_doc_number] => 20210386783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => USE OF GLUCOSYLCERAMIDE SYNTHASE GENE-DEFICIENT T CELL AND THERAPEUTIC UTILIZATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/287670
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287670 | USE OF GLUCOSYLCERAMIDE SYNTHASE GENE-DEFICIENT T CELL AND THERAPEUTIC UTILIZATION THEREOF | Oct 23, 2019 | Abandoned |
Array
(
[id] => 17385936
[patent_doc_number] => 20220033788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => RECOMBINANT COMPONENTS AND COMPOSITIONS FOR USE IN FOOD PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/285589
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285589 | RECOMBINANT COMPONENTS AND COMPOSITIONS FOR USE IN FOOD PRODUCTS | Oct 16, 2019 | Pending |
Array
(
[id] => 16949439
[patent_doc_number] => 20210208130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => ASSAYS FOR CELL-BASED THERAPIES OR TREATMENTS
[patent_app_type] => utility
[patent_app_number] => 17/280486
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280486
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/280486 | ASSAYS FOR CELL-BASED THERAPIES OR TREATMENTS | Sep 26, 2019 | Pending |
Array
(
[id] => 17412781
[patent_doc_number] => 20220047685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => ANIMAL FEED COMPOSITION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/274601
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17274601
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/274601 | ANIMAL FEED COMPOSITION AND USE THEREOF | Sep 10, 2019 | Abandoned |
Array
(
[id] => 17357065
[patent_doc_number] => 20220017861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => UREMIC VASCULOPATHY MODEL USING ENDOTHELIAL CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS AND UREMIC COMPLEX, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/275659
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275659 | UREMIC VASCULOPATHY MODEL USING ENDOTHELIAL CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS AND UREMIC COMPLEX, AND USE THEREOF | Sep 9, 2019 | Pending |
Array
(
[id] => 17007403
[patent_doc_number] => 20210238564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => TELOMERASE HOLOENZYME COMPLEX AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/273880
[patent_app_country] => US
[patent_app_date] => 2019-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273880
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273880 | TELOMERASE HOLOENZYME COMPLEX AND METHODS OF USE THEREOF | Sep 2, 2019 | Pending |
Array
(
[id] => 17170691
[patent_doc_number] => 20210324361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => ENZYMATIC COMPOSITIONS FOR CARBOHYDRATE ANTIGEN CLEAVAGE, METHODS, USES, APPARATUSES AND SYSTEMS ASSOCIATED THEREWITH
[patent_app_type] => utility
[patent_app_number] => 17/269235
[patent_app_country] => US
[patent_app_date] => 2019-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269235 | ENZYMATIC COMPOSITIONS FOR CARBOHYDRATE ANTIGEN CLEAVAGE, METHODS, USES, APPARATUSES AND SYSTEMS ASSOCIATED THEREWITH | Aug 15, 2019 | Abandoned |
Array
(
[id] => 17212265
[patent_doc_number] => 20210345601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ENZYMATIC COMPOSITIONS FOR CARBOHYDRATE ANTIGEN CLEAVAGE ON DONOR ORGANS, METHODS AND USES ASSOCIATED THEREWITH
[patent_app_type] => utility
[patent_app_number] => 17/269238
[patent_app_country] => US
[patent_app_date] => 2019-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269238 | ENZYMATIC COMPOSITIONS FOR CARBOHYDRATE ANTIGEN CLEAVAGE ON DONOR ORGANS, METHODS AND USES ASSOCIATED THEREWITH | Aug 15, 2019 | Abandoned |
Array
(
[id] => 16052455
[patent_doc_number] => 20200188082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => Multilayered Vascular Tubes
[patent_app_type] => utility
[patent_app_number] => 16/540934
[patent_app_country] => US
[patent_app_date] => 2019-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16540934
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/540934 | Multilayered Vascular Tubes | Aug 13, 2019 | Abandoned |
Array
(
[id] => 17140180
[patent_doc_number] => 20210308191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Drug Used for Treating Tissue Necrosis or for Improving Cardiac Function
[patent_app_type] => utility
[patent_app_number] => 17/267586
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267586 | Drug Used for Treating Tissue Necrosis or for Improving Cardiac Function | Aug 8, 2019 | Pending |
Array
(
[id] => 15771451
[patent_doc_number] => 20200116743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => Method of Assessing Liver Triglyceride Levels Using a Body Fluid Sample
[patent_app_type] => utility
[patent_app_number] => 16/532801
[patent_app_country] => US
[patent_app_date] => 2019-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16532801
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/532801 | Method of Assessing Liver Triglyceride Levels Using a Body Fluid Sample | Aug 5, 2019 | Abandoned |
Array
(
[id] => 16086331
[patent_doc_number] => 20200197152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => Platform for Engineered Implantable Tissues and Organs and Methods of Making the Same
[patent_app_type] => utility
[patent_app_number] => 16/531605
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16531605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/531605 | Platform for Engineered Implantable Tissues and Organs and Methods of Making the Same | Aug 4, 2019 | Abandoned |
Array
(
[id] => 16977893
[patent_doc_number] => 20210222130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => MODEL FOR IN-VITRO SIMULATION OF THE BEHAVIOUR OF DYSFUNCTIONAL VESSELS
[patent_app_type] => utility
[patent_app_number] => 17/259898
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259898
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259898 | MODEL FOR IN-VITRO SIMULATION OF THE BEHAVIOUR OF DYSFUNCTIONAL VESSELS | Aug 4, 2019 | Abandoned |
Array
(
[id] => 15408511
[patent_doc_number] => 20200024577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => Method of Producing a Mycological Product and Product Made Thereby
[patent_app_type] => utility
[patent_app_number] => 16/519384
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16519384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/519384 | Method of Producing a Mycological Product and Product Made Thereby | Jul 22, 2019 | Pending |
Array
(
[id] => 19142437
[patent_doc_number] => 20240141275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => SYSTEMS AND METHODS FOR EXPANSION AND DIFFERENTIATION OF THERAPEUTIC CELLS IN BIOREACTORS
[patent_app_type] => utility
[patent_app_number] => 16/517902
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517902
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/517902 | SYSTEMS AND METHODS FOR EXPANSION AND DIFFERENTIATION OF THERAPEUTIC CELLS IN BIOREACTORS | Jul 21, 2019 | Pending |
Array
(
[id] => 16913992
[patent_doc_number] => 20210187084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => INJECTION TECHNIQUES FOR THE TREATMENT OF CELLULITE
[patent_app_type] => utility
[patent_app_number] => 17/259784
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259784
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259784 | INJECTION TECHNIQUES FOR THE TREATMENT OF CELLULITE | Jul 11, 2019 | Pending |
Array
(
[id] => 17020984
[patent_doc_number] => 20210244855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => USE OF AN EXTRACELLULAR MATRIX (ECM) HYDROGEL AS AN ESOPHAGEAL SUBMUCOSAL FLUID CUSHION
[patent_app_type] => utility
[patent_app_number] => 17/254029
[patent_app_country] => US
[patent_app_date] => 2019-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12891
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254029 | USE OF AN EXTRACELLULAR MATRIX (ECM) HYDROGEL AS AN ESOPHAGEAL SUBMUCOSAL FLUID CUSHION | Jun 19, 2019 | Abandoned |
Array
(
[id] => 15150325
[patent_doc_number] => 20190353640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/422031
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422031
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/422031 | ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF | May 23, 2019 | Abandoned |
Array
(
[id] => 15559843
[patent_doc_number] => 20200064333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/422045
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422045
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/422045 | ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF | May 23, 2019 | Abandoned |
Array
(
[id] => 15270123
[patent_doc_number] => 20190383796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/422052
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/422052 | ECM COMPOSITION, TUMOR MICROENVIRONMENT PLATFORM AND METHODS THEREOF | May 23, 2019 | Abandoned |